$Moleculin Biotech(MBRX)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001659617-20-000106 Act: 34 Size: 2 MB 网页链接
$Moleculin Biotech(MBRX)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001659617-20-000102 Act: 34 Size: 218 KB 网页链接
$Moleculin Biotech(MBRX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001659617-20-000097 Act: 34 Size: 219 KB 网页链接
$Moleculin Biotech(MBRX)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-20-000717 Act: 33 Size: 1 KB 网页链接
$Moleculin Biotech(MBRX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001659617-20-000094 Act: 34 Size: 220 KB 网页链接
$Moleculin Biotech(MBRX)$ DEF 14A Other definitive proxy statements Accession Number: 0001659617-20-000090 Act: 34 Size: 647 KB 网页链接
$Moleculin Biotech(MBRX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001659617-20-000087 Act: 34 Size: 224 KB 网页链接
$Moleculin Biotech(MBRX)$ PRE 14A Other preliminary proxy statements Accession Number: 0001659617-20-000083 Act: 34 Size: 647 KB 网页链接
$Moleculin Biotech(MBRX)$ 8-K Current report, item 3.01 Accession Number: 0001659617-20-000079 Act: 34 Size: 192 KB 网页链接
$Moleculin Biotech(MBRX)$ S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001659617-20-000076 Act: 33 Size: 456 KB 网页链接